Helyx Industries S.p.A. (BIT:HLX)
Italy · Delayed Price · Currency is EUR 0.7400
-0.0100 (-1.33%)
Aug 14, 2026, 7:08 PM CET
Helyx Industries Revenue
In the year 2025, Helyx Industries had annual revenue of 2.23M EUR with 88.83% growth. Helyx Industries had revenue of 1.65M in the half year ending December 31, 2025.
Revenue (ttm)
2.30M
Revenue Growth
+70.43%
P/S Ratio
9.98
Revenue / Employee
n/a
Employees
22
Market Cap
19.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.23M | 1.05M | 88.83% |
| Dec 31, 2024 | 1.18M | 920.08K | 349.64% |
| Dec 31, 2023 | 263.15K | -260.62K | -49.76% |
| Dec 31, 2022 | 523.78K | 108.95K | 26.26% |
| Dec 31, 2021 | 414.83K | -347.85K | -45.61% |
| Dec 31, 2020 | 762.68K | 395.13K | 107.50% |
| Dec 31, 2019 | 367.55K | 152.34K | 70.78% |
| Dec 31, 2018 | 215.21K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| Farmacosmo | 56.13M |